SRC and MEK Co-inhibition Synergistically Enhances the Anti-tumor Effect in Both Non-small-cell Lung Cancer (NSCLC) and Erlotinib-Resistant NSCLC
Yuan, Man, Xu, Lin-feng, Zhang, Juan, Kong, Si-yuan, Wu, Man, Lao, Yuan-zhi, Zhou, Hua, Zhang, Li, Xu, HongxiVolume:
9
Journal:
Frontiers in Oncology
DOI:
10.3389/fonc.2019.00586
Date:
July, 2019
File:
PDF, 2.75 MB
2019